➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Merck
Baxter
Medtronic

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Pyrrole-2-Carboxylate


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Pyrrole-2-Carboxylate?

Pyrrole-2-Carboxylate is an investigational drug.

There have been 6 clinical trials for Pyrrole-2-Carboxylate. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2020.

The most common disease conditions in clinical trials are Breast Neoplasms, Urinary Calculi, and Calculi. The leading clinical trial sponsors are West China Hospital, University of Texas Southwestern Medical Center, and UNC Lineberger Comprehensive Cancer Center.

There is one US patent protecting this investigational drug and nine international patents.

Recent Clinical Trials for Pyrrole-2-Carboxylate
TitleSponsorPhase
Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast CancerWest China HospitalPhase 2
Effect of Rosuvastatin on the Clinical Features of PreeclampsiaAssiut UniversityPhase 2
Prophylactic Anticoagulation for Catheter-related ThrombosisSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4

See all Pyrrole-2-Carboxylate clinical trials

Clinical Trial Summary for Pyrrole-2-Carboxylate

Top disease conditions for Pyrrole-2-Carboxylate
Top clinical trial sponsors for Pyrrole-2-Carboxylate

See all Pyrrole-2-Carboxylate clinical trials

US Patents for Pyrrole-2-Carboxylate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyrrole-2-Carboxylate   Get Started Free Intermediate transfer body, image recording method, and image forming apparatus CANON KABUSHIKI KAISHA (Tokyo, JP)   Get Started Free
Pyrrole-2-Carboxylate   Get Started Free Compounds useful for the treatment of metabolic disorders and synthesis of the same North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC)   Get Started Free
Pyrrole-2-Carboxylate   Get Started Free Image recording method, treatment liquid and ink set Canon Kabushiki Kaisha (Tokyo, JP)   Get Started Free
Pyrrole-2-Carboxylate   Get Started Free Intermediate transfer member and image forming method Canon Kabushiki Kaisha (Tokyo, JP)   Get Started Free
Pyrrole-2-Carboxylate   Get Started Free Compounds CHIESI FARMACEUTICI S.P.A. (Parma, IT)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pyrrole-2-Carboxylate

Drugname Country Document Number Estimated Expiration Related US Patent
Pyrrole-2-Carboxylate European Patent Office EP3260297 2036-06-24   Get Started Free
Pyrrole-2-Carboxylate Japan JP2018001759 2036-06-24   Get Started Free
Pyrrole-2-Carboxylate World Intellectual Property Organization (WIPO) WO2014165816 2033-04-05   Get Started Free
Pyrrole-2-Carboxylate Japan JP2016215640 2035-05-18   Get Started Free
Pyrrole-2-Carboxylate Japan JP6775998 2035-05-18   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Colorcon
Mallinckrodt
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.